Grimes & Company’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $410K | Buy |
|
|||||
|
2025
Q2 | $479K | Sell |
|
|||||
|
2025
Q1 | $545K | Sell |
|
|||||
|
2024
Q4 | $566K | Hold |
|
|||||
|
2024
Q3 | $572K | Hold |
|
|||||
|
2024
Q2 | $465K | Buy |
|
|||||
|
2024
Q1 | $363K | Sell |
|
|||||
|
2023
Q4 | $433K | Sell |
|
|||||
|
2023
Q3 | $521K | Buy |
|
|||||
|
2023
Q2 | $512K | Buy |
|
|||||
|
2023
Q1 | $603K | Buy |
|
|||||
|
2022
Q4 | $825K | Sell |
|
|||||
|
2022
Q3 | $907K | Buy |
|
|||||
|
2022
Q2 | $751K | Buy |
|
|||||
|
2022
Q1 | $1.12M | Buy |
|
|||||
|
2021
Q4 | $907K | Buy |
|
|||||
|
2021
Q3 | $757K | Buy |
|
|||||
|
2021
Q2 | $800K | Sell |
|
|||||
|
2021
Q1 | $526K | Buy |
|
|||||
|
2020
Q4 | $268K | Buy |
|
|||||
|
2020
Q3 | $52K | Buy |
|